Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)
China · Delayed Price · Currency is CNY 5.44
-0.22 (-3.89%)
Jun 2, 2026, 3:00 PM CST
SHA:600488 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 26.41 | 70.56 | 133.45 | 117.05 | 35.41 | 48.67 |
Depreciation & Amortization | 289.67 | 289.67 | 296.84 | 271.09 | 257.07 | 205.27 |
Other Amortization | -41.73 | -41.73 | - | 1.82 | 0.15 | 4.04 |
Loss (Gain) From Sale of Assets | -0.4 | -0.4 | 0.03 | -0.65 | 0.94 | 0.02 |
Asset Writedown & Restructuring Costs | 152.13 | 152.13 | 45.67 | 51.42 | 136.53 | 56.26 |
Loss (Gain) From Sale of Investments | 0.8 | 0.8 | 9.09 | 1.13 | 22.44 | -4.99 |
Provision & Write-off of Bad Debts | 0.07 | 0.07 | - | -0.02 | 0.02 | -0.26 |
Other Operating Activities | 80.66 | 37.35 | 52.55 | 21.43 | -35.94 | 55.56 |
Change in Accounts Receivable | -276.79 | -276.79 | 77.31 | -163.08 | 87.75 | -210.34 |
Change in Inventory | 65.26 | 65.26 | 95 | 431.73 | -194.44 | 126.07 |
Change in Accounts Payable | -138.48 | -138.48 | -152.15 | 52.22 | 351.63 | 34.88 |
Operating Cash Flow | 135.63 | 136.48 | 569.37 | 783.01 | 653.52 | 316.89 |
Operating Cash Flow Growth | -73.27% | -76.03% | -27.28% | 19.81% | 106.23% | -8.65% |
Capital Expenditures | -51.39 | -55.91 | -77.74 | -133.15 | -202.2 | -370.84 |
Sale of Property, Plant & Equipment | 7.8 | 7.79 | 1.95 | 1.03 | 4.07 | 0.68 |
Cash Acquisitions | - | - | - | - | - | -10.17 |
Divestitures | - | - | -0.4 | - | - | - |
Investment in Securities | -12.22 | -12.22 | - | - | - | - |
Other Investing Activities | 111.38 | 111.38 | - | - | - | 3.37 |
Investing Cash Flow | 55.57 | 51.04 | -76.19 | -132.12 | -198.13 | -376.96 |
Short-Term Debt Issued | - | - | - | - | 155 | 175 |
Long-Term Debt Issued | - | 329.13 | 780.49 | 580.5 | 1,098 | 1,527 |
Total Debt Issued | 138 | 329.13 | 780.49 | 580.5 | 1,253 | 1,702 |
Short-Term Debt Repaid | - | - | - | -77 | -30 | -303.05 |
Long-Term Debt Repaid | - | -172.28 | -1,229 | -995.57 | -1,185 | -1,229 |
Total Debt Repaid | -198.03 | -172.28 | -1,229 | -1,073 | -1,215 | -1,532 |
Net Debt Issued (Repaid) | -60.03 | 156.85 | -448.37 | -492.07 | 38.09 | 169.23 |
Repurchase of Common Stock | - | - | -4.77 | -5.78 | -8.69 | -1.74 |
Common Dividends Paid | -126.45 | -127.05 | -123.37 | -47.75 | -60.26 | -58.22 |
Other Financing Activities | -30.51 | -15.73 | -41 | -19.25 | -23.71 | -16.58 |
Financing Cash Flow | -216.99 | 14.08 | -617.52 | -564.85 | -54.57 | 92.69 |
Foreign Exchange Rate Adjustments | -2.93 | 0.01 | 15.89 | 8.17 | 0.59 | 1.33 |
Net Cash Flow | -28.72 | 201.61 | -108.44 | 94.2 | 401.41 | 33.95 |
Free Cash Flow | 84.24 | 80.57 | 491.63 | 649.86 | 451.33 | -53.95 |
Free Cash Flow Growth | -80.96% | -83.61% | -24.35% | 43.99% | - | - |
Free Cash Flow Margin | 3.08% | 2.77% | 15.29% | 17.18% | 12.23% | -1.44% |
Free Cash Flow Per Share | 0.08 | 0.07 | 0.45 | 0.59 | 0.41 | -0.05 |
Cash Interest Paid | - | - | - | - | 4.83 | 0.92 |
Cash Income Tax Paid | 153.85 | 129.93 | 139.86 | 194.44 | 167.01 | 147.23 |
Levered Free Cash Flow | 18.48 | -3.52 | 434.19 | 480.9 | 427.86 | -78.42 |
Unlevered Free Cash Flow | 31.04 | 9.23 | 452.21 | 503.82 | 457.96 | -49.73 |
Change in Working Capital | -371.96 | -371.96 | 31.73 | 319.75 | 236.91 | -47.67 |